Print this page
Friday, December 23, 2016 Written by Dr. Jean Michel Cayuela

Analytical and economic evaluation of the fully automated Xpert BCR-ABL Monitor* Assay

Real-World Workshop Series Webinar - July 2012

Dr. Jean Michel Cayuela

Hear Dr Jean-Michel Cayuela provide an introduction to molecular pathology, targeted therapy and the importance of treatment response monitoring within chronic myeloid leukaemia (CML). Dr Cayuela also discusses current BCR-ABL fusion transcript quantitation and standardisation challenges. To round out his presentation he introduces the latest Cepheid Xpert® BCR-ABL* assay, a valuable tool for monitoring patient treatment in a standardised way which allows for data alignment on the International Scale.


*Xpert BCR-ABL Monitor is CE-IVD marked and not available for sale in the USA.